Navigation Links
Eyeforpharma's Marketing Summit is shaping up to be the biggest event of its kind ever
Date:9/9/2008

Pharma’s Successful changing marketing approaches

LONDON, September 8, 2008 / b3c newswire /  – The looming recession certainly does not seem to have hit the European pharmaceutical industry yet.  With more than twice as many registered attendees as in past years, eyeforpharma’s upcoming Marketing Summit Europe, October 20-21 in Zurich is shaping up to be the biggest event of its kind ever.

Companies obviously know that thriving in today’s market means staying on top of their game and perhaps nowhere is that more important than in the rapidly changing pharmaceutical space.

Ultimately, the most successful pharmaceutical companies,  says Michael Zaiac, assistant vice president medical affairs EMEA at Wyeth, will be those who invest heavily in understanding the industry’s new stakeholders – especially patients, payers and policy makers – and employ an early feedback loop into their clinical discovery and development programs to steer products toward better meeting the needs of these stakeholders.

Companies that are quick on the uptake and willing to invest in the necessary skill sets to connect with these new customers, by either acquiring them from outside or training existing employees, Zaiac says, can positively differentiate themselves from their competitors and bring products to market more successfully.

Baba Awopetu, Manager of Brand Strategy EMEA at Stryker, says more stakeholders mean a more complex and complicated environment, and pharma marketers must consider where the power base lies and how much influence each group has given a company’s specific circumstances. Companies may find they have primary and secondary stakeholders, depending on the therapy area, product lifecycle or other factors, he suggests.

With a wider audience, pharmas will need to focus, prioritize and better target their messages, Awopetu says. “We have to cover a lot more with less, so our messages must be better targeted and our marketing efficiency is being forced to improve,” he says.

To learn more about marketing to pharma’s changing customer base, join Zaiac and Awopetu, who will be speaking and chairing sessions at eyeforpharma’s Marketing Summit Europe, October 20-21 in Zurich. For additional details or to register, visit www.eyeforpharma.com/marketing08/


'/>"/>
b3c newswire

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
6. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
7. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
8. Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
9. Phlo Affiliate Names Director Of Marketing
10. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
11. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... CAESAREA, Israel , March 27, 2017 ... company with mobile health and big data solutions, today ... party insurance coverage option for U.S. consumers who ... DarioHealth has signed strategic alliance agreements ... to verify insurance coverage benefits, and if approved, will ...
(Date:3/24/2017)... ROCKVILLE, Md. , March 24, 2017  Infectex ... Fund (MBVF), today announced positive results of a Phase ... drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis ... by scientists at Sequella, Inc. ( USA ... A total of 140 patients were enrolled ...
(Date:3/24/2017)... 2017 On Thursday, March 23, ... 5,817.69, down 0.07%; the Dow Jones Industrial Average edged ... 500 closed at 2,345.96, marginally dropping 0.11%. US markets ... green, 4 sectors finished in red, and 1 sector ... initiated reports coverage on the following Biotechnology equities: BioDelivery ...
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, Jake Lubinski, describes ... characteristics when deformed, which is identical to how the human discs work to ... and return to its natural state along a hysteresis curve, exactly like a ...
Breaking Biology Technology:
(Date:3/23/2017)... March 23, 2017 The report "Gesture Recognition and Touchless ... and Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is ... of 29.63% between 2017 and 2022. Continue Reading ... ... ...
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
Breaking Biology News(10 mins):